The relationship between thyroid eye disease and radioiodine treatment

被引：1

作者：

Thou, Sarameth ^{[1
,2
]}

Vinjamuri, Sobhan ^{[1
]}

机构：

[1] Calmette Univ Hosp, Natl Canc Ctr, Dept Nucl Med, Phnom Penh 12201, Cambodia

[2] Royal Univ Hosp NHS Trust, Dept Nucl Med, Liverpool, Merseyside, England

来源：

NUCLEAR MEDICINE COMMUNICATIONS | 2019年 / 40卷 / 03期

关键词：

Graves' disease; iodine-131; thyroid eye disease; DOSE I-131 THERAPY; GRAVES ORBITOPATHY; TRANSIENT HYPOTHYROIDISM; CIGARETTE-SMOKING; HYPERTHYROID DISEASES; CALCULATED ACTIVITY; RISK-FACTORS; OPHTHALMOPATHY; IODINE; SEVERITY;

D O I：

10.1097/MNM.0000000000000965

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Thyroid eye disease is the most frequent extrathyroidal manifestation of Graves' disease and it can have a major negative impact on the quality of life of affected patients. Therefore, it is crucial to have a correct and early diagnosis. Thyroid eye disease management should be multidisciplinary.

引用

页码：194 / 198

页数：5

共 65 条

[1] The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: Prevalence, mechanism and prognosis [J].

Aizawa, Y ;

Yoshida, K ;

Kaise, N ;

Fukazawa, H ;

Kiso, Y ;

Sayama, N ;

Hori, H ;

Abe, K .

CLINICAL ENDOCRINOLOGY, 1997, 46 (01) :1-5

[2]

AIZAWA Y, 1995, CLIN ENDOCRINOL, V42, P517

[3] High dose 131I therapy for the treatment of hyperthyroidism caused by Graves' disease [J].

Alexander, EK ;

Larsen, PR .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) :1073-1077

[4] EFFECT OF RADIO-IODINE ON STIMULATORY ACTIVITY OF GRAVES IMMUNOGLOBULINS [J].

ATKINSON, S ;

MCGREGOR, AM ;

KENDALLTAYLOR, P ;

PETERSON, MM ;

SMITH, BR .

CLINICAL ENDOCRINOLOGY, 1982, 16 (06) :537-543

[5] MECHANISMS OF DISEASE Graves' Ophthalmopathy [J].

Bahn, Rebecca S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (08) :726-738

[6] Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy [J].

Bartalena, L ;

Marcocci, C ;

Bogazzi, F ;

Manetti, L ;

Tanda, ML ;

Dell'Unto, E ;

Bruno-Bossio, G ;

Nardi, M ;

Bartolomei, MP ;

Lepri, A ;

Rossi, G ;

Martino, E ;

Pinchera, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (02) :73-78

[7] USE OF CORTICOSTEROIDS TO PREVENT PROGRESSION OF GRAVES OPHTHALMOPATHY AFTER RADIOIODINE THERAPY FOR HYPERTHYROIDISM [J].

BARTALENA, L ;

MARCOCCI, C ;

BOGAZZI, F ;

PANICUCCI, M ;

LEPRI, A ;

PINCHERA, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (20) :1349-1352

[8] Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO [J].

Bartalena, Luigi ;

Baldeschi, Lelio ;

Dickinson, Alison ;

Eckstein, Anja ;

Kendall-Taylor, Pat ;

Marcocci, Claudio ;

Mourits, Maarten ;

Perros, Petros ;

Boboridis, Kostas ;

Boschi, Antonella ;

Curro, Nicola ;

Daumerie, Chantal ;

Kahaly, George J. ;

Krassas, Gerasimos E. ;

Lane, Carol M. ;

Lazarus, John H. ;

Marino, Michele ;

Nardi, Marco ;

Neoh, Christopher ;

Orgiazzi, Jacques ;

Pearce, Simon ;

Pinchera, Aldo ;

Pitz, Susanne ;

Salvi, Mario ;

Sivelli, Paolo ;

Stahl, Matthias ;

von Arx, Georg ;

Wiersinga, Wilmar M. .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 158 (03) :273-285

[9] Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism [J].

Boelaert, K. ;

Syed, A. A. ;

Manji, N. ;

Sheppard, M. C. ;

Holder, R. L. ;

Gough, S. C. ;

Franklyn, J. A. .

CLINICAL ENDOCRINOLOGY, 2009, 70 (01) :129-138

[10] Propylthiouracil before 131I therapy of hyperthyroid diseases:: Effect on cure rate evaluated by a randomized clinical trial [J].

Bonnema, SJ ;

Bennedbæk, FN ;

Veje, A ;

Marving, J ;

Hegedüs, L .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09) :4439-4444

← 1 2 3 4 5 6 7 →